NCT01705522|Unknown
Multimodal Approach in IBD Patients
MAID
Loading search results
MAID
Sponsor study identifier
observational
50
1 country
1
Study Start
October 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The investigators intend to assess the role of several biomarkers in the prediction of relapse in IBD. Clinical, laboratory and endoscopic data will be gathered and a predictive score will be derived in order to assess the relapse risk at 1 year.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2012
Date type not reportedThis date has not been verified as actual or estimated.
October 10, 2012
Actual (reported)October 12, 2012
Actual (reported)September 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
October 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Clinical relapse
clinical relapse as assessed by conventional scores for activity in IBD - Mayo or CDAI
1 year
Prevalence of NAFLD
to assess the prevalence of nonalcoholic liver disease in IBD patients
1 year
prevalence of vitamin D deficiency
to assess vitamin D deficiency and osteopenia among IBD patients
1 year
patients with ulcerative colitis or crohn's disease, in remission
all patients with IBD over 18 years of age, currently in clinical remission
Colentina Clinical Hospital
Bucharest, 020125, Romania
Dionne S, Hiscott J, D'Agata I, Duhaime A, Seidman EG. Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies. Dig Dis Sci. 1997 Jul;42(7):1557-66. doi: 10.1023/a:1018895500721.
Voiosu T, Bengus A, Dinu R, Voiosu AM, Balanescu P, Baicus C, Diculescu M, Voiosu R, Mateescu B. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study. J Gastrointestin Liver Dis. 2014 Sep;23(3):273-8. doi: 10.15403/jgld.2014.1121.233.thv.
serum and fecal samples
Theodor Voiosu, Md
Clinical Hospital Colentina
First Submitted
October 10, 2012
First Posted
October 12, 2012
Study Start
October 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2019
Endomicroscopy in IBD Patients
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 2019
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
January 31, 2019
Record last verified: 2019-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: